COVID-19 vaccination status in people with spinal cord injury: Results from a cross-sectional study in Thailand
Issued Date
2023-01-01
Resource Type
ISSN
10790268
eISSN
20457723
Scopus ID
2-s2.0-85152007467
Pubmed ID
36988422
Journal Title
Journal of Spinal Cord Medicine
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Spinal Cord Medicine (2023)
Suggested Citation
Chotiyarnwong C., Pattanakuhar S., Srisuppaphon D., Komaratat N., Insook S., Tunwattanapong P., Kammuang-lue P., Laohasinnarong P., Potiart T., Kaewma A., Thoowadaratrakool T., Potiruk P., Mahisanan T., Wangchumthong A., Kaewtong A., Kittiwarawut J., Dissaneewate T., Kovindha A. COVID-19 vaccination status in people with spinal cord injury: Results from a cross-sectional study in Thailand. Journal of Spinal Cord Medicine (2023). doi:10.1080/10790268.2022.2154733 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/82517
Title
COVID-19 vaccination status in people with spinal cord injury: Results from a cross-sectional study in Thailand
Author's Affiliation
Other Contributor(s)
Abstract
Objective: To assess COVID-19 vaccination status among individuals with spinal cord injury (SCI). Design: A cross-sectional study. Setting: Twelve hospitals from all regions of Thailand. Participants: One hundred and eighty people with SCI were randomly selected from the Thai SCI registry database. Intervention: Not applicable. Outcome measures: The primary outcome, which was the COVID-19 vaccination status, and the secondary outcomes, which were the number of vaccination doses, satisfaction and dissatisfaction aspects, and barriers to vaccination, were recorded using a specifically developed questionnaire over the telephone during February to March 2022. Data were analyzed using descriptive analyses, bivariate, and multivariable analyses. Results: Of the 96 people with SCI who were able to respond, the prevalence of receiving at least one dose was 77% but the prevalence of receiving a booster dose was 20%. Being non-traumatic SCI correlated negatively with having received any vaccination doses when compared to traumatic SCI. Most of the participants were satisfied with the government provision of COVID-19 vaccines. The major barriers to vaccination were problems related to a negative attitude toward the vaccination, followed by transportation difficulties and wheelchair-inaccessible vaccination sites. Conclusions: Seventy-seven percent of people with SCI participating in this study received at least one dose of the COVID-19 vaccine, whereas only 20% of them received a booster dose of the COVID-19 vaccination. To increase the prevalence of vaccination, healthcare providers should deliver the fact regarding COVID-19 vaccination to reduce negative attitudes, as well as remove physical barriers to vaccination places for people with SCI.